The axis of ?MGB1 and soluble RAGE levels in pleural effusions from various etiologies. Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019
Neurotrophin protein expression in pleural effusions Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Local levels of CC and CXC chemokines characterise pleural effusions of different etiologies Source: Eur Respir J 2002; 20: Suppl. 38, 557s Year: 2002
Chemokine characterisation of IFN-γ-deficient pleural effusions from patients with pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor alpha and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
Importance of complement C3-C4 levels on differential diagnosis of pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005
Can VEGF be used in differential diagnosis of pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Expression of TGF-β1 and TGFβ receptors in lung tissue of patients with idiopathic interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
The implication of C-reactive protein in differentiation of various pleural effusion etiologies Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Analysis of T-cell subsets in patients with tuberculous pleural effusions Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005
The expression of PD-1 on CD8+ T cells in malignant pleural effusion of lung cancer and its associated significance Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010